Shopping Cart
- Remove All
- Your shopping cart is currently empty
TLR7/8-IN-1, a crystalline TLR7/TLR8 inhibitor from patent WO2019220390 (compound 2b), is a valuable compound for autoimmune disease research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 179 € | In Stock | |
5 mg | 455 € | In Stock | |
10 mg | 682 € | In Stock | |
25 mg | 1.159 € | In Stock | |
50 mg | 1.605 € | In Stock | |
100 mg | 2.156 € | In Stock |
Description | TLR7/8-IN-1, a crystalline TLR7/TLR8 inhibitor from patent WO2019220390 (compound 2b), is a valuable compound for autoimmune disease research. |
In vitro | TLR7/8-IN-1, a crystalline TLR7/TLR8 inhibitor from patent WO2019220390 (compound 2b), is a valuable compound for autoimmune disease research.[1] |
Alias | TLR7/8-IN-1 |
Molecular Weight | 532.68 |
Formula | C29H40N8O2 |
Cas No. | 2205095-75-4 |
Smiles | Cc1nn(CC23CCC(CC2)(CC3)NC(=O)[C@@H]2COCCN2)c2CCN(Cc12)c1cc(C)nc2n(C)ncc12 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 11.2 mg/mL (21.1 mM ), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.